US Patent Issued to GENEQUANTUM HEALTHCARE (SUZHOU) on Aug. 5 for "Immobilized endoglycosidase fusion protein and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,377,151, issued on Aug. 5, was assigned to GENEQUANTUM HEALTHCARE (SUZHOU) Co. LTD. (Suzhou, China).

"Immobilized endoglycosidase fusion protein and use thereof" was invented by Cao Lv (Suzhou, China), Jinduo Yuan (Suzhou, China), Gang Qin (Suzhou, China) and Meijun Xiong (Suzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method for preparing an antibody-drug conjugate. The antibody-drug conjugate is formed by means of site-directed conjugation on the basis of an N-glycosylation site of an Fc region of an antibody. The method comprises: (1) providing a donor containing an oxazoline oligosaccharide, an antibody containing a GlcNAc motif, and ...